Scabies

Jump to navigation Jump to search

Template:DiseaseDisorder infobox

This page is about clinical aspects of the disease.  For microbiologic aspects of the causative organism(s), see Sarcoptes scabiei.

For patient information click here

WikiDoc Resources for Scabies

Articles

Most recent articles on Scabies

Most cited articles on Scabies

Review articles on Scabies

Articles on Scabies in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Scabies

Images of Scabies

Photos of Scabies

Podcasts & MP3s on Scabies

Videos on Scabies

Evidence Based Medicine

Cochrane Collaboration on Scabies

Bandolier on Scabies

TRIP on Scabies

Clinical Trials

Ongoing Trials on Scabies at Clinical Trials.gov

Trial results on Scabies

Clinical Trials on Scabies at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Scabies

NICE Guidance on Scabies

NHS PRODIGY Guidance

FDA on Scabies

CDC on Scabies

Books

Books on Scabies

News

Scabies in the news

Be alerted to news on Scabies

News trends on Scabies

Commentary

Blogs on Scabies

Definitions

Definitions of Scabies

Patient Resources / Community

Patient resources on Scabies

Discussion groups on Scabies

Patient Handouts on Scabies

Directions to Hospitals Treating Scabies

Risk calculators and risk factors for Scabies

Healthcare Provider Resources

Symptoms of Scabies

Causes & Risk Factors for Scabies

Diagnostic studies for Scabies

Treatment of Scabies

Continuing Medical Education (CME)

CME Programs on Scabies

International

Scabies en Espanol

Scabies en Francais

Business

Scabies in the Marketplace

Patents on Scabies

Experimental / Informatics

List of terms related to Scabies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Synonyms and keywords: Norwegian scabies

Overview

Historical Perspective

Pathophysiology

Pathogenesis

Microscopic Pathology

The histopathology of scabies consists of mites being surrounded by an inflammatory infiltrate of eosinophils, lymphocytes and histiocytes.[1][2][3]

Causes

Differentiating Scabies from Other Diseases

Epidemiology and Demographics

Epidemiology

Demographics

Age

Race

Risk Factors

The following are believed to be risk factors for scabies:[4][1][5][6][7][8][9][10]

  • Living in high-risk areas, such as Sub-Saharan Africa and indigenous communities in Australia and New Zealand
  • Living in crowded areas
  • Homeless or displaced children
  • Poor hygiene: the role of poor hygiene in the development of scabies is uncertain, as mites burrowed under the skin remain alive even after daily hot baths and are usually resistant to water and soap
  • Immunocompromised individuals, such as the elderly, malnourished and those with HIV, DM are at risk of developing Norwegian Scabies, which is the severe form

Natural History, Complications and Prognosis

Natural History

Complications

Major complications of scabies include:[4][1][11]

Prognosis

Diagnosis

History and Symptoms

Physical Examination

In patients with scabies, skin should be carefully examined to look for:[1][4][12][13][10][14][15]

  • Burrows: are the tunnels which the female mite penetrates into the skin. Initially, they are not clinically visible and can only be seen several days later, when the host immune system forms a local reaction around the tunnel. Burrows are characterized by short, wavy lines.
  • Papules: they are usually small and erythematous. The distribution of the papules is variable; they can be sparse or very close to each other. Over the course of the infection, papules can transform into vesicles and/or bullae. Characteristic distribution of scabies usually involves the web spaces of fingers and toes, the wrists and penis. The back is usually spared, while face and neck involvement are usually only seen in infants and children.
  • Excoriations: skin excoriations are commonly seen in patients with scabies, due to the intense itching associated with the infection.

Laboratory Findings

  • Peripheral IgE levels are elevated in patients with Norwegian Scabies.[2][3]

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

References

  1. 1.0 1.1 1.2 1.3 Heukelbach J, Feldmeier H (2006). "Scabies". Lancet. 367 (9524): 1767–74. doi:10.1016/S0140-6736(06)68772-2. PMID 16731272.
  2. 2.0 2.1 Roberts LJ, Huffam SE, Walton SF, Currie BJ (2005). "Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature". J. Infect. 50 (5): 375–81. doi:10.1016/j.jinf.2004.08.033. PMID 15907543.
  3. 3.0 3.1 Arlian LG, Morgan MS, Estes SA, Walton SF, Kemp DJ, Currie BJ (2004). "Circulating IgE in patients with ordinary and crusted scabies". J. Med. Entomol. 41 (1): 74–7. PMID 14989349.
  4. 4.0 4.1 4.2 Romani L, Steer AC, Whitfeld MJ, Kaldor JM (2015). "Prevalence of scabies and impetigo worldwide: a systematic review". Lancet Infect Dis. 15 (8): 960–7. doi:10.1016/S1473-3099(15)00132-2. PMID 26088526.
  5. Kristensen JK (1991). "Scabies and Pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation". Int. J. Dermatol. 30 (10): 699–702. PMID 1955222.
  6. Estrada B (2003). "Ectoparasitic infestations in homeless children". Semin Pediatr Infect Dis. 14 (1): 20–4. doi:10.1053/spid.2003.127213. PMID 12748918.
  7. Currie BJ, Connors CM, Krause VL (1994). "Scabies programs in aboriginal communities". Med. J. Aust. 161 (10): 636–7. PMID 7968739.
  8. Terry BC, Kanjah F, Sahr F, Kortequee S, Dukulay I, Gbakima AA (2001). "Sarcoptes scabiei infestation among children in a displacement camp in Sierra Leone". Public Health. 115 (3): 208–11. doi:10.1038/sj/ph/1900748. PMID 11429717.
  9. Andrews JR, Tonkin SL (1989). "Scabies and pediculosis in Tokelau Island children in New Zealand". J R Soc Health. 109 (6): 199–203. PMID 2513405.
  10. 10.0 10.1 Heukelbach J, Wilcke T, Winter B, Feldmeier H (2005). "Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in Brazil". Br. J. Dermatol. 153 (1): 150–6. doi:10.1111/j.1365-2133.2005.06591.x. PMID 16029341.
  11. Engelman D, Kiang K, Chosidow O, McCarthy J, Fuller C, Lammie P, Hay R, Steer A (2013). "Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies". PLoS Negl Trop Dis. 7 (8): e2167. doi:10.1371/journal.pntd.0002167. PMC 3738445. PMID 23951369.
  12. Chakrabarti A (1985). "Some epidemiological aspects of animal scabies in human population". Int J Zoonoses. 12 (1): 39–52. PMID 4055268.
  13. Burgess I (1994). "Sarcoptes scabiei and scabies". Adv. Parasitol. 33: 235–92. PMID 8122567.
  14. Steer AC, Jenney AW, Kado J, Batzloff MR, La Vincente S, Waqatakirewa L, Mulholland EK, Carapetis JR (2009). "High burden of impetigo and scabies in a tropical country". PLoS Negl Trop Dis. 3 (6): e467. doi:10.1371/journal.pntd.0000467. PMC 2694270. PMID 19547749.
  15. Lawrence G, Leafasia J, Sheridan J, Hills S, Wate J, Wate C, Montgomery J, Pandeya N, Purdie D (2005). "Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin". Bull. World Health Organ. 83 (1): 34–42. doi:/S0042-96862005000100012 Check |doi= value (help). PMC 2623469. PMID 15682247.

Template:WH Template:WS